The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

A new technology may allow patients to recover vision for conditions that were previously thought irreversible ...

No changes in protocol recommended for LUGANO and LUCIA clinical trials –– Masked safety data continues to show no safety signals, consistent ...

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third quarter ended September 30, 2025.

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third ...

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.

Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...

Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition affects the back of the eye where light is processed by ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

Secondary techniques are needed to address macular holes in patients with myopia, according to a speaker at OSN New York ...

Students at the Anatomical Institute of the University of Innsbruck have been the first to utilise the devices.

Preliminary studies suggest GLP-1s may offer long-term vision protection for people without diabetes, but researchers caution more research is still needed. During a 10-year study, people without ...